Navigation Links
Chemo Combo Shows Promise Against Ovarian Cancer
Date:4/19/2009

Lab-based study focused on certain types of malignancies

SUNDAY, April 19 (HealthDay News) -- Adding the drug dasatinib to a standard, two-drug chemotherapy regimen for treating ovarian cancer boosted the effectiveness of the drugs in laboratory tests, new research shows.

Researchers at the Duke Comprehensive Cancer Center added dasatinib, along with carboplatin and paclitaxel, to four types of ovarian cancer cells.

In some types of ovarian cancers, a pathway called SRC is involved in the abnormal cell proliferation, said Dr. Deanna Teoh, a fellow in gynecologic oncology at Duke and lead investigator on this study.

"By examining gene expression data, we determined that the combination of the leukemia drug dasatinib (Sprycel) made carboplatin and paclitaxel more effective in cell lines with higher levels of SRC expression and SRC pathway deregulation," Teoh said.

Dasatinib, which is marketed by Bristol-Meyers Squibb under the brand name Sprycel, is FDA-approved for treating leukemia.

"These findings indicate that we may be able to direct the use of a targeted therapy like dasatinib based on gene expression pathways in select ovarian cancers," she said.

The results of the study were to be presented Sunday at the American Association for Cancer Research annual meeting, in Denver.

Researchers examined four ovarian cancer cell lines, known as IGROV1, SKOV3, OVCAR3 and A2780. Three of the cell lines demonstrated high activation of SRC, and one demonstrated lower SRC expression. All were treated in lab dishes with various combinations of the chemotherapy drugs dasatinib, carboplatin and paclitaxel.

"We found that the addition of dasatinib to standard therapy in the three cell lines with significant SRC pathway deregulation -- IGROV1, OVCAR3 and A2780 -- enhanced the response of the cancer cells to therapy," Teoh said. "Conversely, in SKOV3, which has minimal SRC protein
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Chemotherapy may be culprit for fatigue in breast cancer survivors
2. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
3. To evade chemotherapy, some cancer cells mimic stem cells
4. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
5. PET scans can accurately detect a breast tumors response to chemotherapy
6. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
7. New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog
8. Medicare modernization act did not change chemotherapy as feared
9. HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds
10. Cancer conflict with chemotherapy treatment
11. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Many patients with knee osteoarthritis have continued pain ... someone you know) have chronic pain and problems with ... in the ACT-OA clinical trial. , Kevin Darr, ... one of fifteen physicians in the U.S. to receive ... part of a new, multi-site, double blind, placebo-controlled clinical ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 In a new ... Polish mesothelioma patients reported that shoulder pain was their first ... on its website. Click here to read it now. ... analyzed the medical records of 49 mesothelioma patients ... reported that it was shoulder pain that first prompted them ...
(Date:3/6/2015)... Los Angeles cosmetic dentist , Dr. ... whitening. Zoom is a special type of teeth whitening treatment ... teeth whitening treatments, Zoom does its job in about an ... a limited time, Dr. Ghasri is offering Zoom for just ... of $650 and allows patients to try out this revolutionary ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... to be discussed, Ford & Associates Nationwide Legal Services, ... January 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., ... of California. , “In light of a recently ... used Benicar to evaluate and explore the Mayo Clinic's ...
(Date:3/5/2015)... 05, 2015 Shania Twain will be ... a decade. She has hinted that this will be her ... her perform one last time. She has had a residency ... country sweetheart has millions of loyal fans around the world. ... country, Canada, and on June 30th she will be at Madison ...
Breaking Medicine News(10 mins):Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3
... fibrillation study, blood-thinning drug best for those at highest risk ... Older patients, or those with a prior history of stroke, ... to treat atrial fibrillation, a common heart rhythm disorder, a ... researchers also say the drug is especially beneficial for patients ...
... provide research model, possible treatment for type 1 diabetes in ... skin cells from people with type 1 diabetes, researchers were ... changing blood sugar levels, though not as efficiently as normal ... experiment is that scientists now have a preliminary lab model ...
... new report finds , MONDAY, Aug. 31 (HealthDay News) -- ... a pull on medical sleuths nearly 50 years after the ... Navy physician claims that Kennedy suffered from a more complex ... as a young man. , In the Sept. 1 issue ...
... get their care based on how long it takes to ... Center have recently documented a growing trend in the centralization ... which are generally located in metropolitan areas. While trends ... the Journal of Clinical Oncology shows that there ...
... Blue Cross Blue Shield of ... ... new H1N1 (swine) flu puts increased emphasis on preparing early for the upcoming flu season. The ... flu shot as soon as possible. Since both the seasonal flu and the new H1N1 (swine) ...
... , , , ... 31 Healthspottr Media LLC, a new media and publishing ... through innovation today with the launch of the Annual Healthspottr ... award qualified recipients with prizes of up to $250,000 each ...
Cached Medicine News:Health News:Oldest Heart Patients May Get Most From Warfarin 2Health News:Researchers Make Insulin-Producing Cells From Adult Skin Cells 2Health News:Researchers Make Insulin-Producing Cells From Adult Skin Cells 3Health News:JFK's Health Problems More Complex Than Thought 2Health News:JFK's Health Problems More Complex Than Thought 3Health News:Does the distance a patient has to travel affect where they choose to get their care? 2Health News:Flu Season Preparation Comes Early 2Health News:Flu Season Preparation Comes Early 3Health News:Flu Season Preparation Comes Early 4Health News:Healthspottr Launches New Fellows Program for Health Innovators 2Health News:Healthspottr Launches New Fellows Program for Health Innovators 3
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5. März 2015  Die amerikanische Bill ... biopharmazeutische Unternehmen CureVac geben heute bekannt, dass ... US-Dollar) in CureVac investiert. CureVac ist weltweit ... (mRNA). Auf Basis dieses Moleküls entwickelt CureVac ... und zum Schutz vor Infektionskrankheiten. ...
(Date:3/5/2015)... -- CANTEL MEDICAL CORP. (NYSE: CMN ) will ... 2015 on Thursday, March 12 before the market opens, and ... AM ET. To participate in the conference ... the beginning of the call. If you are unable to ... from Thursday, March 12, 2015 through midnight on May 12, ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
...  BioMed Realty Trust, Inc. (NYSE: BMR ) ... with Depomed, Inc. (NASDAQ: DEPO ) at ... a specialty pharmaceutical company, leased approximately 60,000 square feet ... Realty,s multi-tenant Pacific Research Center campus. Commenting ...
... Fla., April 9, 2012 Med-Tek a developer of Healthcare ... physicians, employers and their constituents today announces the launch ... According to the United States Bone ... individuals suffering from musculoskeletal disease ...
Cached Medicine Technology:New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 2New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 3Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2
Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 80 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: